×
Demant Inventory 2012-2024 | WILYY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Demant inventory for the quarter ending June 30, 2024 was
$0.413B
, a
9.74% increase
year-over-year.
Demant inventory for 2024 was
$0.363B
, a
12.25% decline
from 2023.
Demant inventory for 2023 was
$0.413B
, a
0.46% increase
from 2022.
Demant inventory for 2022 was
$0.411B
, a
9.24% increase
from 2021.
View More
Demant Inventory 2012-2024 | WILYY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Demant inventory for 2024 was
$0.363B
, a
12.25% decline
from 2023.
Demant inventory for 2023 was
$0.413B
, a
0.46% increase
from 2022.
Demant inventory for 2022 was
$0.411B
, a
9.24% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$231B
Boston Scientific (BSX)
$155.5B
Stryker (SYK)
$147.4B
EssilorLuxottica (ESLOY)
$140.8B
Medtronic (MDT)
$112.8B
Lonza Group Ag (LZAGY)
$47.1B
Haleon (HLN)
$44.8B
GE HealthCare Technologies (GEHC)
$42.1B
Agilent Technologies (A)
$39B
ResMed (RMD)
$34.2B
Terumo (TRUMY)
$26.3B
Koninklijke Philips (PHG)
$23.5B
Zimmer Biomet Holdings (ZBH)
$20.6B
Insulet (PODD)
$20.2B
Baxter (BAX)
$17.1B
Sunny Optical Technology (SNPTF)
$11.3B
Smith & Nephew SNATS (SNN)
$11.2B
BellRing Brands (BRBR)
$9.5B
Bio-Rad Laboratories (BIO)
$8B
Lantheus Holdings (LNTH)
$5.6B
Prestige Consumer Healthcare (PBH)
$4.2B
ICU Medical (ICUI)
$4B
Envista Holdings (NVST)
$3.7B
Perrigo (PRGO)
$3.4B
Haemonetics (HAE)
$3.2B
Shandong Weigao Medical Polymer (SHWGF)
$3B
GN Store Nord (GNNDY)
$2.9B
QuidelOrtho (QDEL)
$2.8B
LeMaitre Vascular (LMAT)
$2.3B
Neogen (NEOG)
$2.2B